CDTX vs TSM
Cidara Therapeutics Inc (CDTX) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
TSM (TSM) common stock.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
TSM does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. TSM currently screens at market cap $0.
Not investment advice. Open the CDTX and TSM stock pages for the full models.
Not investment advice.